Stock LLM Wiki

報告_MS_大立光3008升評_20260709

更新 2026-07-13

PDF 原檔:報告_MS_大立光3008升評_20260709_original.pdf

圖片清單(已驗證 2026-07-13)

檔名 size 分類 親眼所見內容
_001.png 66511 裝飾·banner 「Asia Summer School 2026」廣告 banner,泳池背景配文字,非資料圖
_004.png 60986 真資料圖 Consensus Price Target Distribution + Risk Reward Chart:現價 NT$3,950,MS 新 TP NT$4,836(+22.43%),情境上緣 NT$9,007(+128.03%)/下緣 NT$2,924(-25.97%)
_007.png 43330 真資料圖 FY2027e 一致預期 vs MS 估計 dumbbell 圖:Sales/Revenue、EBITDA、Net income、EPS 四項比較(MS Estimates vs Mean)
_008.png 69738 真資料圖 Largan 目標價歷史階梯圖(2023-07~2026-07),標示歷次評等調整(O/I=Overweight/In-line、E/I=Equal-weight/In-line)與股價走勢

_002.png(31041B)、_003.png(31358B)、_005.png(19720B)、_006.png(21383B)均 <40KB,依規則預設略過(未逐張驗證)。

原始內容

M July 9, 2026 09:00 PM GMT

Largan Precision | Asia Pacific

Fiber Array Project Likely to Kick Off in 2H26; Upgrade to OW

What's Changed

Largan Precision (3008.TW) From To
Rating Equal-weight Overweight
Price Target NT$2,450.00 NT$4,836.00

Reaction to earnings

Strengthens our thesis

Impact to our thesis

Source: Company data, Morgan Stanley Research

The smartphone low season is behind us while the stock has incorporated the CPO-related enthusiasm fade with a 20%+ correction from the peak. However, now we expect a significant new CPO opportunity and seasonal smartphone recovery, and upgrade the stock to OW with a new price target of TW$4,836.

Key Takeaways

  • Decent 2Q26 results with 17% YoY revenue growth and 352% YoY net profit growth.
  • CPO-related (Fiber Array) has made continued progress and management expects pilot production to kick off in 2H26.
  • We believe Largan has good growth potential in CPO opportunity and add positive value of TW$2,022/share into our valuation.

Smartphone low season is behind us: After shipments declined continuously from March 26 to June 26, we expect a seasonal recovery to begin, with a sequential increase highly likely in the coming months. What's more, the key client's foldable smartphone has seen orders increase from 8 mn units to 10 mn units based on Nikkei Asia (link). If the new product performs well in 4Q26, it could become a positive catalyst for the smartphone business.

Adding the potential positive value from CPO opportunity: Management

highlighted that sampling will occur in July, while pilot production could kick off right after. If so, Largan could start this new journey in 2H26. We view this new business development as a significant positive driver for Largan, given its strong optical know-how and excessive cash balance on hand. However, we believe the current share price is already pricing in such new business opportunity, therefore, in Exhibit 2 we conclude that a 20% market share in FAU could boost Largan's earnings by >40% in 2028 and beyond. Applying a 35x P/E to these incremental

Modest upside

Financial results versus consensus

Modest revision higher

Direction of next 12-month consensus EPS

Morgan Stanley Asia Limited+

Andy Meng, CFA

Equity Analyst Andy.Meng@morganstanley.com

+852 2239-7689

Betty Chen

Research Associate

Betty.H.Chen@morganstanley.com

+852 2239-7213

報告_MS_大立光3008升評_20260709_001

Largan Precision (3008.TW, 3008 TT)

Greater China Technology Hardware | Taiwan

Stock Rating Industry View

Overweight In-Line

Price target Up/downside to price target (%) Shr price, close (Jul 9, 2026)

NT$4,836.00

22

NT$3,950.00

52-Week Range

NT$5,360.00-

2,020.00

Sh out, dil, curr (mn)

134

Mkt cap, curr (mn)

NT$529,854

EV, curr (mn)

NT$398,645

Avg daily trading value (mn)

NT$3,050

Fiscal Year Ending 12/25 12/26e 12/27e 12/28e
EPS (NT$)** 159.40 175.24 182.48 182.90
Prior EPS (NT$)** - 153.49 165.87 165.88
Revenue, net (NT$ mn) 61,148 64,900 70,170 72,297
EBITDA (NT$ mn) 31,260 32,862 35,472 36,341
ModelWare net inc (NT 21,275 23,388 24,355 24,411
$ mn)
P/E 15.7 22.5 21.6 21.6
P/BV 1.7 2.5 2.2 2.0
ROE (%) 11.5 12.3 11.4 10.2

Unless otherwise noted, all metrics are based on Morgan Stanley ModelWare framework

** = Based on consensus methodology

e = Morgan Stanley Research estimates

Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.